— Know what they know.
Not Investment Advice
Also trades as: NVO (NYSE) · $vol 469M · NOVO-B.CO (CPH) · $vol 179M · NOV.DE (XETRA) · $vol 8M · NOVC.DE (XETRA) · $vol 5M · NOVO.TO (TSX) · $vol 0M

NONOF OTC

Novo Nordisk A/S
1W: -4.3% 1M: -21.0% 3M: -24.3% YTD: -29.8% 1Y: -35.0% 3Y: -57.8% 5Y: -22.6%
$37.01
-0.37 (-0.99%)
 
Weekly Expected Move ±4.1%
$34 $36 $37 $39 $40
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 43 · $164.3B mcap · 3.15B float · 0.0023% daily turnover · Short 13% of daily vol

📊 Key Metrics

TTM
$329B
Revenue
+5.6% YoY
$116B
Net Income
+4.8% YoY
$76B
Free Cash Flow
+22.8% YoY
78.2%
Gross Margin
34.5%
Op. Margin
26.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE59.8%
ROA21.6%
ROIC35.2%

Valuation

P/E9.5
P/B5.0
EV/EBITDA0.0

Leverage

Debt/Equity0.63
Current Ratio0.87
Interest Cov.168.5x

Quality Scores

Piotroski F5/9
Altman Z—
Beneish M-2.29

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms